Sep 29, 2023 05:39AM

Sep 28, 2023 09:00PM

Sep 26, 2023 08:02AM

Sep 14, 2023 05:27PM

Aug 8, 2022 11:01AM

Aug 8, 2022 11:00AM

Aug 8, 2022 11:00AM Vaccinex, Inc.’s Phase 2 “SIGNAL” Study to Evaluate Pepinemab Antibody in Huntington’s Disease is Published in Nature Medicine along with Detailed Mechanism of Action Study in Journal of Neuro

Aug 9, 2018 09:08AM

Aug 8, 2018 06:02AM

64,524 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All